Factor 2, Technical Approach Sample Clauses

Factor 2, Technical Approach. The evaluation will assess the extent to which the Offeror possesses the expertise, knowledge and capabilities for successful performance of the requirements identified in the TOR and PWS. The evaluation will assess the description/qualifications/certifications and Resumes of the proposed employees to include proposed subcontractors. In order to receive a rating of Acceptable in the technical factor an Offeror must include resumes of the number of personnel that supports the Offerors approach. Technical Capability Volume shall provide methodology that contractor would use for accomplishing/satisfying the Performance Work Statement. Do not merely reiterate the objectives or reformulate the requirements specified in the PWS.
AutoNDA by SimpleDocs
Factor 2, Technical Approach. (i) Solicitation Submittal Requirements:
Factor 2, Technical Approach. Do not include cost information in the technical approach narratives. In a narrative form, as a minimum, submit your company’s technical approach to performing the Technical Provisions (TPs) listed below. Technical approach narratives may be enhanced with charts, tables, or any logical means of conveying the proposed technical approach the Offeror will use to accomplish a TP. Broad general statements that merely mimic a TP, repeat, paraphrase, or promise general performance are not sufficient. In submitting the Technical Approach Proposal, the Offeror shall be required to fully complete the Section L- Technical Approach worksheets as provided for Section L. The Offeror is responsible for the accuracy of all data input. All TPs in Section C are to be addressed. Offerors are cautioned to use the most current worksheet information in the solicitation or in the latest amendment. The Offeror may not alter a requirement within the worksheets, as this may prevent the Technical Team’s ability to evaluate the technical proposal effectively. The maximum page limitation to include charts, tables, etc. is limited to 200 pages* for Factor 2: Technical Approach. Any information past this number will not be evaluated. *This page limit does not include any spreadsheets that the Government requires to be submitted with the Technical Approach Proposal. For this source selection, a technical approach for the TPs listed below are to be discussed: TP-1 Administration and Base Labor TP-2 Management Reimbursable Requirements TP-3 Cleaning Services and Refuse Removal TP-4 Grass Mowing TP-5 Boundary Line Maintenance TP-6 Maintenance and Repair of Buildings, Recreation Facilities and Associated Infrastructure TP-7 Lock and Dam Maintenance TP-8 Maintenance of Upland Dredged Material Disposal Areas TP-9 Protection and Enhancement of Natural Resources TP-10 Maintenance of Government Vehicles, Boats, and Equipment TP-11 Grounds Maintenance
Factor 2, Technical Approach. (i) Solicitation Submittal Requirements: Provide labor hours by submitting a completed Attachment JL-1 Labor Hours worksheet (MS Excel, Microsoft Office Version 2016 compatible) for the total effort to include the prime contractor, affiliates/subsidiaries/parent/LLC/LTD member companies, and all subcontractors for the base period of performance. Provide the number of labor hours proposed for performing each technical specification item as provided on Attachment JL-1. Provide a narrative of your rationale for the Basis of Estimate (BOE) according to the annual total labor hours for each technical specification to include individual labor classifications. Explain the methodology used to develop the number of labor hours for the base period and state the estimate data source(s) (such as RS Means Facilities Maintenance & Repair Cost Data, CBRE Facilities Maintenance & Repair Cost Data, etc.). Your narrative shall include how the proposed approach and labor hours will effectively achieve each performance objective and associated performance standard(s) for each technical specification while coordinating, managing, and supervising workforce personnel across all technical specifications simultaneously. Additionally, the narrative shall describe the methodology for service orders (all types) and demonstrate an understanding of all limits of liability identified in each respective spec item. Describe how you will staff the organization including the relationship between overall management (corporate and on-site), administration, affiliates/subsidiaries/parent /LLC/LTD member companies, and subcontractors to include Spec Items 1, 2, 3, and 4 personnel.

Related to Factor 2, Technical Approach

  • SHOP DRAWINGS, PRODUCT DATA AND SAMPLES 4.12.1 Shop Drawings are drawings, diagrams, schedules and other, data specially prepared for the Work by the Contractor or any Subcontractor, manufacturer, supplier or distributor to illustrate some portion of the Work.

  • Vendor Development Rights To the extent not inconsistent with Customer’s rights in the Work Product or as set forth herein, nothing in this Contract shall preclude Vendor from developing for itself, or for others, materials which are competitive with those produced as a result of the Services provided hereunder, provided that no Work Product is utilized, and no Intellectual Property Rights of Customer therein are infringed by such competitive materials. To the extent that Vendor wishes to use the Work Product, or acquire licensed rights in certain Intellectual Property Rights of Customer therein in order to offer competitive goods or services to third parties, Vendor and Customer agree to negotiate in good faith regarding an appropriate license and royalty agreement to allow for such.

  • MSAA Indicator Technical Specification Document This Agreement shall be interpreted with reference to the MSAA Indicator Technical Specifications document.

  • Product Technical Support & Maintenance Licensee shall have the option of electing the Product technical support and maintenance (“maintenance”) set forth in the Contract by giving written notice to Contractor any time during the Centralized Contract term. Maintenance term(s) and any renewal(s) thereof are independent of the expiration of the Centralized Contract term and will not automatically renew. Maintenance shall include, at a minimum, (i) the provision of error corrections, updates, revisions, fixes, upgrade and new releases to Licensee, and (ii) Help Desk assistance with locally accessible “800” or toll free, local telephone service, or alternatively on-line Help Desk accessibility. Contractor shall maintain the Products so as to provide Licensee with the ability to utilize the Products in accordance with the Product documentation without significant functional downtime to its ongoing business operations during the maintenance term. Authorized User shall not be required to purchase maintenance for use of Product, and may discontinue maintenance at the end of any current maintenance term upon notice to Contractor. In the event that Authorized User does not initially acquire or discontinues maintenance of licensed Product, it may, at any time thereafter, reinstate maintenance for Product without any additional penalties or other charges, by paying Contractor the amount which would have been due under the Contract for the period of time that such maintenance had lapsed, at then current NYS net maintenance rates.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • For Product Development Projects and Project Demonstrations  Published documents, including date, title, and periodical name.  Estimated or actual energy and cost savings, and estimated statewide energy savings once market potential has been realized. Identify all assumptions used in the estimates.  Greenhouse gas and criteria emissions reductions.  Other non-energy benefits such as reliability, public safety, lower operational cost, environmental improvement, indoor environmental quality, and societal benefits.  Data on potential job creation, market potential, economic development, and increased state revenue as a result of the project.  A discussion of project product downloads from websites, and publications in technical journals.  A comparison of project expectations and performance. Discuss whether the goals and objectives of the Agreement have been met and what improvements are needed, if any.

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

  • Development Milestones In addition to its obligations under Paragraph 7.1, LICENSEE specifically commits to achieving the following development milestones in its diligence activities under this AGREEMENT: (a) (b).

  • Product Changes Vocera shall have the right, in its absolute discretion, without liability to End User, to update to provide new functionality or otherwise change the design of any Product or to discontinue the manufacture or sale of any Product. Vocera shall notify End User at least 90 days prior to the delivery of any Product which incorporates a change that adversely affects form, fit or function (“Material Change”). Vocera shall also notify End User at least 90 days prior to the discontinuance of manufacture of any Product. Notification will be made as soon as reasonably practical for changes associated with regulatory or health and safety issues.

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

Time is Money Join Law Insider Premium to draft better contracts faster.